Thus, any comparison must be based on existing data from liraglutide's phase 3 trials and retatrutide's phase 2 trials: According to a 2016 systematic review of 43 randomized trials, liraglutide has shown significant benefits for T2D, with doses ranging from 1.2-1.8mg/daily leading to HbA1c decreases between -0.9% and -2.2% over six months
Of course, you should read all current and past customer reviews before signing up, which you can find on trustpilot
The SELECT trial reported a 20% reduction in major adverse cardiovascular events with semaglutide versus placebo in patients with overweight/obesity and established cardiovascular disease, without diabetes [34] [35]
To date, much of the research on the effects of semaglutide on alcohol consumption has involved animal studies, or observational studies with humans
There is no licensed formulation anywhere in the world
They monitor your dosing